Latest Reviews

Sponsored Links

Biosimilar Growth Hormone: Need For Caution

Abstract

The use of biosimilar drugs is increasing. This article reviews the differences between generics and biosimilars, points out the shortcomings in the
regulatory process for biosimilars, and draws attention to the limitations and potential problems of prescribing biosimilars, while focusing on human
growth hormone.

Reviews: 
Volumes and Issues: 

Indian National GLP (Schedule L1) In Comparison To WHO GLP- A Review

Abstract

The objective of the review article is to bring out the differences between the Schedule L1 , Drugs and Cosmetics Act, 1940, Government of India and the WHO Good Practices For Pharmaceutical Quality Control Laboratories, World Health Organisation. This will be particularly useful to the laboratories that already comply with the requirements of Schedule L1 and want to move ahead towards WHO compliance.

Reviews: 
Volumes and Issues: 

You May Also Like..